| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.76B | +5.0% | +0.2% |
| Cost of Revenue | $2.39B | +6.2% | +4.2% |
| Gross Profit | $1.37B | +2.9% | -6.0% |
| R&D Expense | $250.4M | +14.4% | +26.2% |
| SG&A Expense | $886.6M | -4.5% | -11.6% |
| Operating Income | $178.8M | -23.3% | -20.8% |
| Interest Expense | $119.6M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $975.3M | +72.2% | -48.1% |
| Accounts Receivable | $3.37B | +3.5% | -9.3% |
| Inventory | $4.11B | -3.6% | +0.7% |
| Current Assets | $9.95B | +1.8% | -12.0% |
| Total Assets | $37.92B | -1.3% | -15.3% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $1.50B | — | — |
| Capital Expenditures | $182.3M | — | — |
| Investing Cash Flow | -$216.5M | — | — |
| Financing Cash Flow | -$1.06B | — | — |
| Free Cash Flow | $1.32B | — | — |
| +2.6% |
| -17.9% |
| Pre-tax Income | -$7.9M | +96.4% | -108.7% |
| Income Tax | $120.3M | +156.6% | +2897.7% |
| Net Income | -$128.2M | -2687.0% | -235.2% |
| EPS (Basic) | -$0.11 | — | -237.5% |
| EPS (Diluted) | -$0.11 | — | -237.5% |
| $7.36B |
| +3.2% |
| -2.0% |
| Long-term Debt | $12.49B | -2.4% | -12.7% |
| Total Liabilities | $22.70B | -0.6% | -9.0% |
| Stockholders' Equity | $15.22B | -2.3% | -23.1% |